Opana Uptake Slower Than Anticipated, But Script Growth Is On The Rise
This article was originally published in The Pink Sheet Daily
Executive Summary
Scripts for Endo's oral oxymorphone reached 1,137 the week of Sept. 29, according to IMS weekly trend data.